150 related articles for article (PubMed ID: 10023664)
1. The five amino acid-deleted isoform of hepatocyte growth factor promotes carcinogenesis in transgenic mice.
Bell A; Chen Q; DeFrances MC; Michalopoulos GK; Zarnegar R
Oncogene; 1999 Jan; 18(4):887-95. PubMed ID: 10023664
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine.
Horiguchi N; Takayama H; Toyoda M; Otsuka T; Fukusato T; Merlino G; Takagi H; Mori M
Oncogene; 2002 Mar; 21(12):1791-9. PubMed ID: 11896611
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of hepatocyte growth factor on metastasis of hepatocellular carcinoma in transgenic mice.
Shiota G; Kawasaki H; Nakamura T; Schmidt EV
Res Commun Mol Pathol Pharmacol; 1996 Jan; 91(1):33-9. PubMed ID: 8824929
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor and its variant with a deletion of five amino acids are distinguishable in their biological activity and tertiary structure.
Shima N; Tsuda E; Goto M; Yano K; Hayasaka H; Ueda M; Higashio K
Biochem Biophys Res Commun; 1994 Apr; 200(2):808-15. PubMed ID: 8179615
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of c-myc mRNA after completion of liver regeneration in transgenic mice expressing hepatocyte growth factor in liver.
Shiota G; Kawasaki H; Nakamura T; Schmidt EV
Res Commun Mol Pathol Pharmacol; 1995 Sep; 89(3):259-68. PubMed ID: 8680795
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte growth factor in transgenic mice: effects on hepatocyte growth, liver regeneration and gene expression.
Shiota G; Wang TC; Nakamura T; Schmidt EV
Hepatology; 1994 Apr; 19(4):962-72. PubMed ID: 8138271
[TBL] [Abstract][Full Text] [Related]
7. Sp1 regulates expression of MET, and ribozyme-induced down-regulation of MET in fibrosarcoma-derived human cells reduces or eliminates their tumorigenicity.
Liang H; O'Reilly S; Liu Y; Abounader R; Laterra J; Maher VM; McCormick JJ
Int J Oncol; 2004 May; 24(5):1057-67. PubMed ID: 15067326
[TBL] [Abstract][Full Text] [Related]
8. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor transforms immortalized mouse liver epithelial cells.
Kanda H; Tajima H; Lee GH; Nomura K; Ohtake K; Matsumoto K; Nakamura T; Kitagawa T
Oncogene; 1993 Nov; 8(11):3047-53. PubMed ID: 8414505
[TBL] [Abstract][Full Text] [Related]
10. Reduced hepatocyte proliferation is the basis of retarded liver tumor progression and liver regeneration in mice lacking N-acetylglucosaminyltransferase III.
Yang X; Tang J; Rogler CE; Stanley P
Cancer Res; 2003 Nov; 63(22):7753-9. PubMed ID: 14633700
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
Price JA; Kovach SJ; Johnson T; Koniaris LG; Cahill PA; Sitzmann JV; McKillop IH
Hepatology; 2002 Nov; 36(5):1089-97. PubMed ID: 12395318
[TBL] [Abstract][Full Text] [Related]
12. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
[TBL] [Abstract][Full Text] [Related]
13. Constitutive c-Met signaling through a nonautocrine mechanism promotes metastasis in a transgenic transplantation model.
Yu Y; Merlino G
Cancer Res; 2002 May; 62(10):2951-6. PubMed ID: 12019177
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor promotes lung carcinogenesis in transgenic mice treated with diethylnitrosamine.
Kojima A; Horiguchi N; Kakizaki S; Takayama H; Mori M
Anticancer Res; 2013 Mar; 33(3):895-901. PubMed ID: 23482759
[TBL] [Abstract][Full Text] [Related]
15. A mutant of deleted variant of hepatocyte growth factor (dHGF) with alanine substitution in the N-terminal basic region has higher activity in vivo.
Kinosaki M; Yamaguchi K; Yamashita Y; Uematsu Y; Aihara H; Masunaga H; Morinaga T; Higashio K
Biochem Biophys Res Commun; 1999 Jan; 254(2):363-7. PubMed ID: 9918843
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte growth factor levels in liver and serum increase during chemical hepatocarcinogenesis.
Burr AW; Hillan KJ; McLaughlin KE; Ferrier R; Chapman C; Mathew J; Burt AD
Hepatology; 1996 Nov; 24(5):1282-7. PubMed ID: 8903411
[TBL] [Abstract][Full Text] [Related]
17. Assessment of in vitro growth potential of hepatocytes expressing hepatocyte growth factor in an autocrine fashion.
Shiota G; Kawasaki H; Nakamura T; Schmidt EV
Res Commun Mol Pathol Pharmacol; 1994 Aug; 85(2):151-6. PubMed ID: 7994559
[TBL] [Abstract][Full Text] [Related]
18. Characterization of double transgenic mice expressing hepatocye growth factor and transforming growth factor alpha.
Shiota G; Kawasaki H; Nakamura T; Schmidt EV
Res Commun Mol Pathol Pharmacol; 1995 Oct; 90(1):17-24. PubMed ID: 8581343
[TBL] [Abstract][Full Text] [Related]
19. Ectopic activity of fibroblast growth factor receptor 1 in hepatocytes accelerates hepatocarcinogenesis by driving proliferation and vascular endothelial growth factor-induced angiogenesis.
Huang X; Yu C; Jin C; Kobayashi M; Bowles CA; Wang F; McKeehan WL
Cancer Res; 2006 Feb; 66(3):1481-90. PubMed ID: 16452204
[TBL] [Abstract][Full Text] [Related]
20. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
